Avalon Pharmaceuticals, Inc. (AVRX)

[surf1944]

Avalon Pharmaceuticals to Present at the American Association for Cancer Research 2008 Annual Meeting
Monday April 7, 8:00 am ET

GERMANTOWN, Md.--(BUSINESS WIRE)--Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX - News), today announced that it will conduct four poster presentations at the American Association for Cancer Research 2008 Annual Meeting, April 12-16, in San Diego, CA.

Abstract #2306, “Identification of Small Molecule Inhibitors of the Aurora/Centrosome Pathway,” will be presented by Irina Lonskaya, Ph.D, Scientist at Avalon, on Monday, April 14, from 8:00 a.m. - 12:00 noon.

Abstract #2929, “An Evaluation of Pharmacodynamic Markers for the Identification of Novel Therapeutic Agents That Modulate the Wnt Signaling Pathway,” will be presented by Pavan Adiseshaiah, Ph.D., Scientist at Avalon, on Monday, April 14, from 1:00 p.m. - 5:00 p.m.

Abstract #226, “Characterization of a Myeloid Leukemia Cell Line Resistant to Inosine Monophosphate Dehydrogenase (IMPDH) Inhibition: Correlation of Molecular Pathway Markers and GTP Depletion with Clinical Biomarkers,” will be presented by Jeffrey Strovel, Ph.D., Senior Scientist at Avalon, on Sunday, April 13, from 8:00 a.m.- 12:00 noon.

Abstract #796, “Avalon Compound Profiling Toolkit: Use of Gene Transcription Biomarker Signatures for Drug Discovery,” will be presented by Qin Zong, Ph.D., Associate Director of Lead Discovery at Avalon, on Sunday, April 13, from 1:00 p.m.- 5:00 p.m.